Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 83

1.

Efficacy and safety of a recombinant anti-immunoglobulin E antibody (omalizumab) in severe allergic asthma.

Holgate ST, Chuchalin AG, Hébert J, Lötvall J, Persson GB, Chung KF, Bousquet J, Kerstjens HA, Fox H, Thirlwell J, Cioppa GD; Omalizumab 011 International Study Group.

Clin Exp Allergy. 2004 Apr;34(4):632-8.

PMID:
15080818
[PubMed - indexed for MEDLINE]
2.

Spotlight on omalizumab in allergic asthma.

Bang LM, Plosker GL.

BioDrugs. 2004;18(6):415-8. Review.

PMID:
15571425
[PubMed - indexed for MEDLINE]
3.

Omalizumab: a review of its use in the management of allergic asthma.

Bang LM, Plosker GL.

Treat Respir Med. 2004;3(3):183-99. Review.

PMID:
15219177
[PubMed - indexed for MEDLINE]
4.

The role of omalizumab in the treatment of severe allergic asthma.

Chapman KR, Cartier A, Hébert J, McIvor RA, Schellenberg RR.

Can Respir J. 2006 Jul-Aug;13 Suppl B:1B-9B. Review.

PMID:
16909166
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Anti-IgE for chronic asthma in adults and children.

Walker S, Monteil M, Phelan K, Lasserson TJ, Walters EH.

Cochrane Database Syst Rev. 2004;(3):CD003559. Review. Update in: Cochrane Database Syst Rev. 2006;(2):CD003559.

PMID:
15266491
[PubMed - indexed for MEDLINE]
6.

Anti-IgE for chronic asthma in adults and children.

Walker S, Monteil M, Phelan K, Lasserson TJ, Walters EH.

Cochrane Database Syst Rev. 2006 Apr 19;(2):CD003559. Review. Update in: Cochrane Database Syst Rev. 2014;1:CD003559.

PMID:
16625585
[PubMed - indexed for MEDLINE]
7.

A recombinant humanized anti-IgE monoclonal antibody (omalizumab) in the therapy of moderate-to-severe allergic asthma.

D'Amato G, Piccolo A, Salzillo A, Noschese P, D'Amato M, Liccardi G.

Recent Pat Inflamm Allergy Drug Discov. 2007 Nov;1(3):225-31. Review.

PMID:
19075985
[PubMed - indexed for MEDLINE]
8.

Omalizumab in the treatment of asthma.

Tan R, Corren J.

Expert Rev Respir Med. 2011 Dec;5(6):747-56. doi: 10.1586/ers.11.73. Review.

PMID:
22082161
[PubMed - indexed for MEDLINE]
9.

Anti-IgE for chronic asthma.

Walker S, Monteil M, Phelan K, Lasserson TJ, Walters EH.

Cochrane Database Syst Rev. 2003;(3):CD003559. Review. Update in: Cochrane Database Syst Rev. 2004;(3):CD003559.

PMID:
12917972
[PubMed - indexed for MEDLINE]
10.

[Anti-IgE therapy in persistent allergic asthma].

Skiepko R, Zietkowski Z, Tomasiak-Łozowska MM, Bodzenta-Łukaszyk A.

Przegl Lek. 2009;66(3):141-4. Review. Polish.

PMID:
19689039
[PubMed - indexed for MEDLINE]
11.

Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy.

Holgate ST, Djukanović R, Casale T, Bousquet J.

Clin Exp Allergy. 2005 Apr;35(4):408-16. Review.

PMID:
15836747
[PubMed - indexed for MEDLINE]
12.

Omalizumab for the treatment of severe persistent allergic asthma in children aged 6-11 years: a NICE single technology appraisal.

Burch J, Griffin S, McKenna C, Walker S, Paton J, Wright K, Woolacott N.

Pharmacoeconomics. 2012 Nov 1;30(11):991-1004. doi: 10.2165/11597160-000000000-00000. Review.

PMID:
22950547
[PubMed - indexed for MEDLINE]
13.

Omalizumab: a review of its use in the treatment of allergic asthma.

Plosker GL, Keam SJ.

BioDrugs. 2008;22(3):189-204. Review.

PMID:
18481901
[PubMed - indexed for MEDLINE]
14.

Anti-immunoglobulin E therapy with omalizumab for asthma.

Hendeles L, Sorkness CA.

Ann Pharmacother. 2007 Sep;41(9):1397-410. Epub 2007 Aug 14. Review.

PMID:
17698897
[PubMed - indexed for MEDLINE]
15.

Omalizumab (Xolair) improves quality of life in adult patients with allergic asthma: a review.

Buhl R.

Respir Med. 2003 Feb;97(2):123-9. Review.

PMID:
12587961
[PubMed - indexed for MEDLINE]
16.

Omalizumab: a monoclonal anti-IgE antibody.

Belliveau PP.

MedGenMed. 2005 Jan 27;7(1):27. Review.

PMID:
16369332
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

The use of omalizumab in the treatment of severe allergic asthma: A clinical experience update.

Holgate S, Buhl R, Bousquet J, Smith N, Panahloo Z, Jimenez P.

Respir Med. 2009 Aug;103(8):1098-113. doi: 10.1016/j.rmed.2009.03.008. Epub 2009 Apr 10. Review. Erratum in: Respir Med. 2010 Jun;104(6):924.

PMID:
19362459
[PubMed - indexed for MEDLINE]
Free Article
18.

[Anti IgE antibodies for the treatment of difficult asthma].

Humbert M, Tonnel AB.

Rev Mal Respir. 2005 Dec;22(6 Pt 1):983-90. Review. French.

PMID:
16222222
[PubMed - indexed for MEDLINE]
19.

Omalizumab: a review of its use in patients with severe persistent allergic asthma.

McKeage K.

Drugs. 2013 Jul;73(11):1197-212. doi: 10.1007/s40265-013-0085-4. Review.

PMID:
23812924
[PubMed - indexed for MEDLINE]
20.

Role of anti-IgE monoclonal antibody (omalizumab) in the treatment of bronchial asthma and allergic respiratory diseases.

D'Amato G.

Eur J Pharmacol. 2006 Mar 8;533(1-3):302-7. Epub 2006 Feb 7. Review.

PMID:
16464445
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk